LATANOPROST

LATANOPROST was reported 50806 times

These side effects are most commonly reported by patients taking LATANOPROST:

# Side effect Count
0 TREATMENT FAILURE 5934
1 DRUG INEFFECTIVE 3298
2 FATIGUE 2383
3 EYE IRRITATION 2305
4 HEADACHE 1854
5 INTRAOCULAR PRESSURE INCREASED 1796
6 EYE PAIN 1689
7 DYSPNOEA 1682
8 DEATH 1680
9 DIARRHOEA 1678
10 DIZZINESS 1663
11 OFF LABEL USE 1652
12 NAUSEA 1603
13 VISION BLURRED 1542
14 FALL 1465
15 CATARACT 1388
16 GLAUCOMA 1372
17 OCULAR HYPERAEMIA 1348
18 PAIN 1327
19 ASTHENIA 1306
20 HYPERSENSITIVITY 1181
21 RASH 1072
22 VISUAL IMPAIRMENT 1030
23 PNEUMONIA 1026
24 MALAISE 1025
25 WEIGHT DECREASED 1001
26 PRURITUS 986
27 COUGH 974
28 CONDITION AGGRAVATED 972
29 PAIN IN EXTREMITY 961
30 ARTHRALGIA 950
31 VOMITING 892
32 HYPERTENSION 864
33 DRUG HYPERSENSITIVITY 763
34 CONSTIPATION 754
35 PRODUCT DOSE OMISSION ISSUE 754
36 EYE PRURITUS 739
37 PYREXIA 721
38 CONFUSIONAL STATE 719
39 VISUAL ACUITY REDUCED 718
40 INSOMNIA 703
41 DRY EYE 702
42 DEPRESSION 676
43 DECREASED APPETITE 665
44 EYE DISORDER 661
45 BACK PAIN 647
46 CEREBROVASCULAR ACCIDENT 633
47 SOMNOLENCE 626
48 ACUTE KIDNEY INJURY 620
49 URINARY TRACT INFECTION 609
50 GAIT DISTURBANCE 603
51 PRODUCT QUALITY ISSUE 592
52 ANAEMIA 571
53 INCORRECT DOSE ADMINISTERED 563
54 BLOOD PRESSURE INCREASED 561
55 ABDOMINAL DISCOMFORT 547
56 ANXIETY 547
57 HYPOTENSION 545
58 PALPITATIONS 541
59 CHEST PAIN 534
60 FEELING ABNORMAL 534
61 PRODUCT USE IN UNAPPROVED INDICATION 527
62 ERYTHEMA 510
63 COVID-19 508
64 PRODUCT USE ISSUE 502
65 PERIPHERAL SWELLING 486
66 ARTHRITIS 485
67 MYALGIA 478
68 BLINDNESS 472
69 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 467
70 ATRIAL FIBRILLATION 465
71 DRUG INTOLERANCE 463
72 MUSCLE SPASMS 461
73 NASOPHARYNGITIS 454
74 TREMOR 452
75 HAEMOGLOBIN DECREASED 448
76 LACRIMATION INCREASED 446
77 RENAL FAILURE 442
78 OEDEMA PERIPHERAL 436
79 ABDOMINAL PAIN UPPER 431
80 ABDOMINAL PAIN 413
81 DEHYDRATION 412
82 WEIGHT INCREASED 410
83 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 406
84 ALOPECIA 403
85 BRONCHITIS 396
86 MUSCULAR WEAKNESS 393
87 SYNCOPE 390
88 EYE SWELLING 378
89 MEMORY IMPAIRMENT 378
90 VERTIGO 378
91 DYSGEUSIA 377
92 MYOCARDIAL INFARCTION 372
93 BALANCE DISORDER 371
94 BLOOD GLUCOSE INCREASED 363
95 ASTHMA 361
96 HYPOAESTHESIA 356
97 PARAESTHESIA 355
98 DRUG INTERACTION 341
99 CARDIAC FAILURE CONGESTIVE 340
100 FOREIGN BODY SENSATION IN EYES 340
101 DRY MOUTH 333
102 TINNITUS 331
103 PULMONARY EMBOLISM 324
104 HALLUCINATION 320
105 CHRONIC KIDNEY DISEASE 315
106 CARDIAC DISORDER 314
107 CHEST DISCOMFORT 313
108 MIGRAINE 311
109 SINUSITIS 302
110 DEEP VEIN THROMBOSIS 297
111 INTENTIONAL PRODUCT USE ISSUE 296
112 STRESS 295
113 LOSS OF CONSCIOUSNESS 294
114 HOT FLUSH 290
115 DIABETES MELLITUS 289
116 DRUG DOSE OMISSION 289
117 JOINT SWELLING 285
118 NEUROPATHY PERIPHERAL 283
119 BLINDNESS UNILATERAL 282
120 CONTUSION 281
121 PRODUCT CONTAINER ISSUE 281
122 DYSPEPSIA 278
123 ADVERSE DRUG REACTION 276
124 HYPONATRAEMIA 276
125 BURNING SENSATION 272
126 GASTROOESOPHAGEAL REFLUX DISEASE 267
127 RECTAL HAEMORRHAGE 265
128 WHITE BLOOD CELL COUNT DECREASED 265
129 GASTROINTESTINAL HAEMORRHAGE 264
130 PHOTOPHOBIA 263
131 MEDICATION ERROR 261
132 OCULAR DISCOMFORT 260
133 PLATELET COUNT DECREASED 260
134 GENERAL PHYSICAL HEALTH DETERIORATION 256
135 HEART RATE INCREASED 255
136 INJECTION SITE PAIN 255
137 INFLUENZA 254
138 RHINORRHOEA 254
139 SEPSIS 254
140 DYSPHONIA 253
141 HAEMATOCHEZIA 253
142 HYPOACUSIS 252
143 BLOOD PRESSURE DECREASED 250
144 HYPERHIDROSIS 248
145 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 248
146 SWOLLEN TONGUE 247
147 ARRHYTHMIA 246
148 PRODUCT SUBSTITUTION ISSUE 246
149 EPISTAXIS 244
150 THROMBOSIS 240
151 HOSPITALISATION 239
152 URTICARIA 239
153 CHILLS 237
154 DISEASE PROGRESSION 237
155 NIGHTMARE 236
156 ECZEMA 235
157 DYSPHAGIA 234
158 WHEEZING 230
159 HAEMORRHAGE 229
160 DRY SKIN 227
161 PRODUCT STORAGE ERROR 227
162 BRADYCARDIA 226
163 OROPHARYNGEAL PAIN 226
164 ACCIDENTAL OVERDOSE 221
165 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 219
166 SKIN EXFOLIATION 219
167 SWELLING 218
168 EYE DISCHARGE 217
169 FREQUENT BOWEL MOVEMENTS 214
170 SLEEP DISORDER 214
171 OSTEOARTHRITIS 210
172 DIVERTICULITIS 208
173 CARDIAC FAILURE 207
174 DYSPNOEA EXERTIONAL 207
175 INFECTION 204
176 SKIN DISCOLOURATION 203
177 PRODUCT DOSE OMISSION 202
178 TUBULOINTERSTITIAL NEPHRITIS 202
179 INTENTIONAL PRODUCT MISUSE 198
180 PRODUCTIVE COUGH 197
181 NASAL CONGESTION 194
182 BRONCHIECTASIS 193
183 NEUTROPENIA 193
184 SWELLING FACE 193
185 TACHYCARDIA 193
186 THERAPY INTERRUPTED 193
187 CATARACT OPERATION 192
188 BLOOD CHOLESTEROL INCREASED 191
189 RHEUMATOID ARTHRITIS 190
190 THROMBOCYTOPENIA 190
191 RHINITIS 188
192 MUSCULOSKELETAL STIFFNESS 187
193 COLITIS ULCERATIVE 186
194 NO ADVERSE EVENT 186
195 MOBILITY DECREASED 184
196 ACCIDENTAL EXPOSURE TO PRODUCT 183
197 CARDIAC MURMUR 182
198 BLOOD CREATININE INCREASED 181
199 PRODUCT CLOSURE REMOVAL DIFFICULT 181
200 RENAL IMPAIRMENT 181
201 PRODUCT PACKAGING QUANTITY ISSUE 180
202 GINGIVAL PAIN 179
203 ABDOMINAL DISTENSION 178
204 PAROSMIA 177
205 RESPIRATORY FAILURE 177
206 THROAT IRRITATION 177
207 ILLNESS 173
208 BLISTER 172
209 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 171
210 SYSTEMIC LUPUS ERYTHEMATOSUS 171
211 HYPERKALAEMIA 170
212 HEPATIC ENZYME INCREASED 169
213 IMPAIRED QUALITY OF LIFE 169
214 LIMB INJURY 169
215 TRANSIENT ISCHAEMIC ATTACK 169
216 FLUSHING 168
217 OVERDOSE 167
218 UNEVALUABLE EVENT 167
219 SEIZURE 166
220 NECK PAIN 164
221 DIPLOPIA 163
222 ARTHROPATHY 162
223 HYPOPNOEA 161
224 NERVOUSNESS 161
225 PULMONARY OEDEMA 161
226 OXYGEN SATURATION DECREASED 160
227 MACULAR DEGENERATION 158
228 BURNS SECOND DEGREE 157
229 IMPAIRED WORK ABILITY 157
230 LETHARGY 157
231 HYPOKALAEMIA 155
232 HEART RATE DECREASED 154
233 POLLAKIURIA 154
234 OEDEMA 152
235 RASH PRURITIC 152
236 FLUID RETENTION 150
237 THYROID DISORDER 150
238 DISCOMFORT 149
239 PRODUCT USE COMPLAINT 149
240 RENAL FAILURE ACUTE 149
241 STEROID DEPENDENCE 148
242 CATARRH 147
243 VISUAL FIELD DEFECT 147
244 C-REACTIVE PROTEIN INCREASED 146
245 ERYTHEMA OF EYELID 146
246 CELLULITIS 145
247 EYE INFLAMMATION 145
248 PLEURAL EFFUSION 145
249 TOXIC EPIDERMAL NECROLYSIS 145
250 EYE INFECTION 144
251 HIP FRACTURE 144
252 AMNESIA 143
253 CORONARY ARTERY DISEASE 143
254 PSORIASIS 143
255 SURGERY 143
256 FLATULENCE 141
257 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 140
258 NEPHROLITHIASIS 139
259 EYE HAEMORRHAGE 137
260 MUSCULOSKELETAL PAIN 137
261 SPEECH DISORDER 137
262 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 136
263 CONJUNCTIVITIS 136
264 GAIT INABILITY 136
265 EYELID OEDEMA 135
266 INTERNATIONAL NORMALISED RATIO INCREASED 135
267 STOMATITIS 135
268 BONE PAIN 134
269 OSTEOPOROSIS 134
270 RENAL DISORDER 134
271 SYNOVITIS 134
272 GASTROINTESTINAL DISORDER 133
273 CARDIAC ARREST 131
274 COLITIS MICROSCOPIC 131
275 HYPOGLYCAEMIA 130
276 PRODUCT DOSE OMISSION IN ERROR 130
277 AGITATION 129
278 BLOOD POTASSIUM DECREASED 129
279 RASH ERYTHEMATOUS 129
280 THERAPY CESSATION 129
281 LUNG DISORDER 128
282 INTRAOCULAR PRESSURE TEST ABNORMAL 127
283 RED BLOOD CELL COUNT DECREASED 127
284 BLOOD PRESSURE FLUCTUATION 124
285 BODY HEIGHT DECREASED 123
286 INFLAMMATION 122
287 DEAFNESS 121
288 TREATMENT NONCOMPLIANCE 120
289 DEMENTIA 118
290 DYSKINESIA 118
291 INFLUENZA LIKE ILLNESS 118
292 MALIGNANT NEOPLASM PROGRESSION 117
293 DISORIENTATION 116
294 HERPES ZOSTER 116
295 END STAGE RENAL DISEASE 115
296 GROWTH OF EYELASHES 115
297 HYPOTHYROIDISM 115
298 SINUS DISORDER 115
299 FEELING HOT 114
300 NEOPLASM MALIGNANT 112
301 SKIN REACTION 112
302 THERAPY NON-RESPONDER 112
303 COMA 111
304 URINARY RETENTION 111
305 HEART RATE IRREGULAR 110
306 HALLUCINATION, VISUAL 109
307 EMOTIONAL DISTRESS 108
308 RESPIRATORY TRACT INFECTION 108
309 PLASMA CELL MYELOMA 107
310 PRODUCT ADMINISTRATION ERROR 107
311 HEAD INJURY 106
312 PANCYTOPENIA 106
313 ADVERSE EVENT 105
314 BLOOD PRESSURE ABNORMAL 105
315 DYSURIA 105
316 ALCOHOL POISONING 104
317 INJURY 104
318 ORTHOSTATIC HYPOTENSION 104
319 RETINAL DETACHMENT 104
320 UPPER RESPIRATORY TRACT INFECTION 104
321 ALANINE AMINOTRANSFERASE INCREASED 103
322 CONJUNCTIVAL HYPERAEMIA 103
323 DRUG EFFECT DECREASED 102
324 LIP SWELLING 102
325 PARKINSON^S DISEASE 102
326 RASH MACULAR 101
327 ABNORMAL SENSATION IN EYE 100
328 ASPARTATE AMINOTRANSFERASE INCREASED 100
329 BLEPHARITIS 100
330 CORNEAL DISORDER 99
331 UPPER GASTROINTESTINAL HAEMORRHAGE 99
332 VITREOUS FLOATERS 99
333 ANGINA PECTORIS 98
334 DISEASE RECURRENCE 98
335 PRODUCT DELIVERY MECHANISM ISSUE 98
336 CYSTITIS 97
337 DRUG ADMINISTRATION ERROR 97
338 HYPOPHAGIA 97
339 CEREBRAL HAEMORRHAGE 96
340 FUNGAL INFECTION 96
341 GASTRITIS 96
342 PHARMACEUTICAL PRODUCT COMPLAINT 96
343 UVEITIS 96
344 DYSARTHRIA 95
345 HAEMATOCRIT DECREASED 95
346 WHITE BLOOD CELL COUNT INCREASED 95
347 INTESTINAL OBSTRUCTION 94
348 PRODUCT DROPPER ISSUE 94
349 THERAPEUTIC RESPONSE UNEXPECTED 94
350 COGNITIVE DISORDER 93
351 DEVICE ISSUE 93
352 INFUSION RELATED REACTION 93
353 LIMB DISCOMFORT 93
354 PROSTATE CANCER 93
355 UNDERDOSE 93
356 WOUND 93
357 CHOLELITHIASIS 92
358 EXPIRED PRODUCT ADMINISTERED 92
359 INJECTION SITE ERYTHEMA 92
360 TOXICITY TO VARIOUS AGENTS 92
361 SUICIDAL IDEATION 91
362 ASTHENOPIA 90
363 FEELING COLD 90
364 POOR QUALITY PRODUCT ADMINISTERED 90
365 SEASONAL ALLERGY 90
366 UPPER LIMB FRACTURE 90
367 URINARY INCONTINENCE 90
368 AGEUSIA 89
369 BLOOD SODIUM DECREASED 89
370 FEBRILE NEUTROPENIA 88
371 GOUT 88
372 HYPERGLYCAEMIA 88
373 THERAPEUTIC PRODUCT EFFECT DECREASED 87
374 DEPRESSED MOOD 86
375 DYSSTASIA 86
376 EYE OPERATION 86
377 EYELID MARGIN CRUSTING 86
378 HYPOXIA 85
379 INJECTION SITE BRUISING 85
380 ORAL PAIN 85
381 RESPIRATORY TRACT CONGESTION 85
382 SKIN IRRITATION 85
383 CORNEAL OEDEMA 84
384 LOCALISED INFECTION 84
385 SKIN DISORDER 84
386 SKIN LESION 84
387 AGGRESSION 83
388 FULL BLOOD COUNT DECREASED 83
389 NIGHT SWEATS 83
390 BREAST CANCER 82
391 EXTRA DOSE ADMINISTERED 82
392 LEUKOPENIA 82
393 RASH PAPULAR 82
394 TASTE DISORDER 82
395 METABOLIC ACIDOSIS 81
396 PAIN IN JAW 81
397 EAR PAIN 80
398 EYELID DISORDER 80
399 EYELID IRRITATION 80
400 FEMUR FRACTURE 80
401 HAEMATEMESIS 80
402 HAEMATOMA 80
403 MADAROSIS 80
404 ACUTE MYOCARDIAL INFARCTION 79
405 DISTURBANCE IN ATTENTION 79
406 FAECES DISCOLOURED 79
407 HAEMATURIA 79
408 PANIC ATTACK 79
409 PRODUCT PACKAGING ISSUE 79
410 SLEEP APNOEA SYNDROME 79
411 ACUTE RESPIRATORY FAILURE 78
412 ILL-DEFINED DISORDER 78
413 BLOOD GLUCOSE DECREASED 77
414 CONTRAINDICATED PRODUCT ADMINISTERED 77
415 HAEMOPTYSIS 77
416 HAEMORRHOIDS 77
417 SCIATICA 77
418 UNRESPONSIVE TO STIMULI 77
419 HYPERSOMNIA 76
420 INTERSTITIAL LUNG DISEASE 76
421 ROAD TRAFFIC ACCIDENT 76
422 SNEEZING 76
423 ATRIAL FLUTTER 75
424 EXPOSURE VIA SKIN CONTACT 75
425 REACTION TO PRESERVATIVES 75
426 RENAL INJURY 75
427 RESPIRATORY DISORDER 75
428 TOOTH DISORDER 75
429 ABASIA 74
430 ABNORMAL BEHAVIOUR 74
431 INTENTIONAL DOSE OMISSION 74
432 MACULAR OEDEMA 74
433 DELUSION 73
434 INJECTION SITE HAEMORRHAGE 73
435 IRRITABILITY 73
436 LABORATORY TEST ABNORMAL 72
437 MIDDLE INSOMNIA 72
438 PANCREATITIS 72
439 THERAPEUTIC RESPONSE DECREASED 72
440 DEPRESSED LEVEL OF CONSCIOUSNESS 71
441 EYELID PTOSIS 71
442 IMPAIRED HEALING 71
443 PRODUCT PACKAGE ASSOCIATED INJURY 71
444 RHABDOMYOLYSIS 71
445 COLITIS 70
446 GASTRIC DISORDER 70
447 PULMONARY HYPERTENSION 70
448 SKIN ULCER 70
449 APHASIA 69
450 BLOOD MAGNESIUM DECREASED 69
451 HOSPICE CARE 69
452 INSTILLATION SITE PAIN 69
453 HEARING IMPAIRED 68
454 HIATUS HERNIA 68
455 PRODUCT AVAILABILITY ISSUE 68
456 PROSTATIC SPECIFIC ANTIGEN INCREASED 68
457 PRURITUS GENERALISED 68
458 RIB FRACTURE 68
459 VIRAL INFECTION 68
460 ANAPHYLACTIC REACTION 67
461 EYELIDS PRURITUS 67
462 HEAD DISCOMFORT 67
463 INCORRECT PRODUCT STORAGE 67
464 NEPHROGENIC ANAEMIA 67
465 OCULAR HYPERTENSION 67
466 OSTEOPENIA 67
467 POST PROCEDURAL COMPLICATION 67
468 SUBDURAL HAEMATOMA 67
469 BLOOD CREATINE PHOSPHOKINASE INCREASED 66
470 BLOOD URINE PRESENT 66
471 CHOKING 66
472 DELIRIUM 66
473 EATING DISORDER 66
474 MENTAL STATUS CHANGES 66
475 MOVEMENT DISORDER 66
476 MUSCULOSKELETAL DISCOMFORT 66
477 SKIN CANCER 66
478 TYPE 2 DIABETES MELLITUS 66
479 ABNORMAL DREAMS 65
480 DEMENTIA ALZHEIMER^S TYPE 65
481 DRUG EFFECT INCOMPLETE 65
482 HAEMORRHAGE INTRACRANIAL 65
483 LIVER DISORDER 65
484 LIVER FUNCTION TEST ABNORMAL 65
485 BLINDNESS TRANSIENT 64
486 BLOOD ALKALINE PHOSPHATASE INCREASED 64
487 BLOOD BILIRUBIN INCREASED 64
488 BLOOD UREA INCREASED 64
489 GAMMA-GLUTAMYLTRANSFERASE INCREASED 64
490 JOINT INJURY 64
491 MENTAL DISORDER 64
492 PRESYNCOPE 64
493 PULMONARY CONGESTION 63
494 SWELLING OF EYELID 63
495 EYELID PAIN 62
496 MELAENA 62
497 MENISCUS INJURY 62
498 MULTIPLE SCLEROSIS 62
499 BASAL CELL CARCINOMA 61
500 BEDRIDDEN 61
501 EAR INFECTION 61
502 PNEUMONIA ASPIRATION 61
503 SKIN LACERATION 61
504 ULCER 61
505 ANGIOEDEMA 60
506 CORNEAL OPACITY 60
507 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 60
508 EMPHYSEMA 60
509 EXPIRED DRUG ADMINISTERED 60
510 LOWER RESPIRATORY TRACT INFECTION 60
511 BLOOD COUNT ABNORMAL 59
512 BLOOD POTASSIUM INCREASED 59
513 BLOOD PRESSURE SYSTOLIC INCREASED 59
514 DARK CIRCLES UNDER EYES 59
515 BACTERIAL INFECTION 58
516 CONVULSION 58
517 CYSTOID MACULAR OEDEMA 58
518 ERECTILE DYSFUNCTION 58
519 EYE ALLERGY 58
520 GLYCOSYLATED HAEMOGLOBIN INCREASED 58
521 HYPERLIPIDAEMIA 58
522 LACTIC ACIDOSIS 58
523 NEOPLASM PROGRESSION 58
524 PHOTOSENSITIVITY REACTION 58
525 PULMONARY FIBROSIS 58
526 STAPHYLOCOCCAL INFECTION 58
527 FULL BLOOD COUNT ABNORMAL 57
528 HERNIA 57
529 INTERVERTEBRAL DISC PROTRUSION 57
530 IRIDOCYCLITIS 57
531 IRON DEFICIENCY ANAEMIA 57
532 NEURALGIA 57
533 NEUTROPHIL COUNT DECREASED 57
534 PERIORBITAL SWELLING 57
535 RESTLESS LEGS SYNDROME 57
536 ANGLE CLOSURE GLAUCOMA 56
537 CEREBRAL INFARCTION 56
538 CHROMATURIA 56
539 DEVICE MALFUNCTION 56
540 FIBROMYALGIA 56
541 HYPOMAGNESAEMIA 56
542 OBSTRUCTIVE AIRWAYS DISORDER 56
543 PERIPHERAL VASCULAR DISORDER 56
544 PRODUCT FORMULATION ISSUE 56
545 PULMONARY MASS 56
546 RENAL CYST 56
547 SKIN BURNING SENSATION 56
548 DERMATITIS ATOPIC 55
549 FEAR 55
550 PERICARDIAL EFFUSION 55
551 SEPTIC SHOCK 55
552 BACK DISORDER 54
553 INTRAOCULAR PRESSURE DECREASED 54
554 KIDNEY INFECTION 54
555 MALIGNANT MELANOMA 54
556 MULTIPLE SCLEROSIS RELAPSE 54
557 PANCREATITIS ACUTE 54
558 PRODUCT COMPLAINT 54
559 RETCHING 54
560 SKIN FISSURES 54
561 SPINAL FRACTURE 54
562 GLOMERULAR FILTRATION RATE DECREASED 53
563 INJECTION SITE PRURITUS 53
564 NOCTURIA 53
565 PHOTOPSIA 53
566 PRESCRIBED UNDERDOSE 53
567 PRODUCT CONTAINER SEAL ISSUE 53
568 DERMATITIS 52
569 ELECTROCARDIOGRAM QT PROLONGED 52
570 ACNE 51
571 EYE COLOUR CHANGE 51
572 EYE OEDEMA 51
573 GLOSSODYNIA 51
574 MUSCULOSKELETAL CHEST PAIN 51
575 OPEN ANGLE GLAUCOMA 51
576 PNEUMONITIS 51
577 POOR QUALITY DRUG ADMINISTERED 51
578 RESPIRATORY DISTRESS 51
579 COLON CANCER 50
580 ERUCTATION 50
581 FEEDING DISORDER 50
582 MUSCULOSKELETAL DISORDER 50
583 OSTEOMYELITIS 50
584 PHARYNGITIS 50
585 ANHEDONIA 49
586 CARDIO-RESPIRATORY ARREST 49
587 DERMATITIS CONTACT 49
588 EYE INJURY 49
589 INTERVERTEBRAL DISC DEGENERATION 49
590 JOINT STIFFNESS 49
591 LYMPHOCYTE COUNT DECREASED 49
592 MUSCLE ATROPHY 49
593 RESTLESSNESS 49
594 TOOTH INFECTION 49
595 ULCERATIVE KERATITIS 49
596 ENCEPHALOPATHY 48
597 FOOT FRACTURE 48
598 INJECTION SITE SWELLING 48
599 POOR QUALITY SLEEP 48
600 TENDONITIS 48
601 ACTIVITIES OF DAILY LIVING IMPAIRED 47
602 APHONIA 47
603 ATRIOVENTRICULAR BLOCK COMPLETE 47
604 EPILEPSY 47
605 LYMPHADENOPATHY 47
606 PHARYNGEAL OEDEMA 47
607 RASH GENERALISED 47
608 SINUS CONGESTION 47
609 SPUTUM DISCOLOURED 47
610 VISUAL DISTURBANCE 47
611 CIRCULATORY COLLAPSE 46
612 DRY THROAT 46
613 ELECTROLYTE IMBALANCE 46
614 GASTRIC ULCER 46
615 HAIR COLOUR CHANGES 46
616 HEART RATE ABNORMAL 46
617 INJECTION SITE REACTION 46
618 LOWER LIMB FRACTURE 46
619 ORAL HERPES 46
620 PALLOR 46
621 PIGMENTATION DISORDER 46
622 PSORIATIC ARTHROPATHY 46
623 RETINAL HAEMORRHAGE 46
624 VITAMIN D DECREASED 46
625 BLOOD CALCIUM DECREASED 45
626 CANDIDA INFECTION 45
627 CORONARY ARTERY OCCLUSION 45
628 GLAUCOMA SURGERY 45
629 GROIN PAIN 45
630 HYPERAESTHESIA 45
631 ISCHAEMIC STROKE 45
632 KERATITIS 45
633 LEUKOCYTOSIS 45
634 MICTURITION URGENCY 45
635 OPTIC NERVE DISORDER 45
636 PLATELET COUNT INCREASED 45
637 PRODUCT PACKAGING DIFFICULT TO OPEN 45
638 SINUS BRADYCARDIA 45
639 TRANSFUSION 45
640 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 44
641 BRONCHOSPASM 44
642 DIABETES MELLITUS INADEQUATE CONTROL 44
643 DIZZINESS POSTURAL 44
644 ENCEPHALITIS 44
645 FACIAL PARALYSIS 44
646 GALLBLADDER DISORDER 44
647 HEMIPARESIS 44
648 INTERNAL HAEMORRHAGE 44
649 LARGE INTESTINE POLYP 44
650 LIQUID PRODUCT PHYSICAL ISSUE 44
651 LUNG NEOPLASM MALIGNANT 44
652 OSTEONECROSIS OF JAW 44
653 PRODUCT DISPENSING ERROR 44
654 SPINAL DISORDER 44
655 ATAXIA 43
656 BLOOD IRON DECREASED 43
657 CARPAL TUNNEL SYNDROME 43
658 EYE LASER SURGERY 43
659 FRACTURE 43
660 HEPATIC FUNCTION ABNORMAL 43
661 HYPERPARATHYROIDISM SECONDARY 43
662 INTRAOCULAR PRESSURE FLUCTUATION 43
663 MITRAL VALVE INCOMPETENCE 43
664 ORAL DISCOMFORT 43
665 PRODUCT PRESCRIBING ISSUE 43
666 PULMONARY THROMBOSIS 43
667 RENAL FAILURE CHRONIC 43
668 THIRST 43
669 THROAT TIGHTNESS 43
670 UROSEPSIS 43
671 CARDIOVASCULAR DISORDER 42
672 CHOROIDAL DETACHMENT 42
673 COAGULOPATHY 42
674 INFUSION SITE PAIN 42
675 IRRITABLE BOWEL SYNDROME 42
676 LIVER FUNCTION TEST INCREASED 42
677 OESOPHAGITIS 42
678 PERIPHERAL COLDNESS 42
679 ROTATOR CUFF SYNDROME 42
680 THERAPEUTIC RESPONSE SHORTENED 42
681 ANAL INCONTINENCE 41
682 ATELECTASIS 41
683 CHOROIDAL EFFUSION 41
684 DIABETIC KETOACIDOSIS 41
685 GENERALISED OEDEMA 41
686 IMPAIRED DRIVING ABILITY 41
687 LOWER GASTROINTESTINAL HAEMORRHAGE 41
688 MUSCLE TIGHTNESS 41
689 NASAL DISCOMFORT 41
690 NERVOUS SYSTEM DISORDER 41
691 SCAB 41
692 UPPER-AIRWAY COUGH SYNDROME 41
693 APATHY 40
694 CLOSTRIDIUM DIFFICILE INFECTION 40
695 DEVICE DELIVERY SYSTEM ISSUE 40
696 HAIR GROWTH ABNORMAL 40
697 HAIR TEXTURE ABNORMAL 40
698 IRITIS 40
699 LARYNGITIS 40
700 MENTAL IMPAIRMENT 40
701 PHLEBITIS 40
702 PRODUCT PHYSICAL ISSUE 40
703 RETINAL DISORDER 40
704 SUICIDE ATTEMPT 40
705 TOOTHACHE 40
706 ABDOMINAL PAIN LOWER 39
707 ACCIDENT 39
708 ANOSMIA 39
709 EAR DISCOMFORT 39
710 EPIDERMAL NECROSIS 39
711 EPIGASTRIC DISCOMFORT 39
712 FEELING JITTERY 39
713 INCREASED TENDENCY TO BRUISE 39
714 JAUNDICE 39
715 SPINAL OSTEOARTHRITIS 39
716 VITREOUS HAEMORRHAGE 39
717 ARTERIAL OCCLUSIVE DISEASE 38
718 BLADDER DISORDER 38
719 BONE DISORDER 38
720 DIVERTICULUM 38
721 EAR DISORDER 38
722 FOOT DEFORMITY 38
723 GASTROENTERITIS 38
724 HYPOCALCAEMIA 38
725 INFARCTION 38
726 KNEE ARTHROPLASTY 38
727 THINKING ABNORMAL 38
728 CARDIOGENIC SHOCK 37
729 CARDIOMEGALY 37
730 HYPOTONY OF EYE 37
731 INSTILLATION SITE IRRITATION 37
732 IRIS HYPERPIGMENTATION 37
733 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 37
734 LOCAL SWELLING 37
735 MACULOPATHY 37
736 MUSCLE TWITCHING 37
737 MYELODYSPLASTIC SYNDROME 37
738 PROTEINURIA 37
739 SECRETION DISCHARGE 37
740 WEIGHT FLUCTUATION 37
741 WRIST FRACTURE 37
742 BLOOD TRIGLYCERIDES INCREASED 36
743 CARDIOMYOPATHY 36
744 CRYING 36
745 DEVICE DISLOCATION 36
746 ECONOMIC PROBLEM 36
747 ESSENTIAL HYPERTENSION 36
748 FACIAL PAIN 36
749 GINGIVAL BLEEDING 36
750 HYPOKINESIA 36
751 INCREASED APPETITE 36
752 INSURANCE ISSUE 36
753 JOINT DISLOCATION 36
754 MACULAR HOLE 36
755 MOUTH ULCERATION 36
756 OBESITY 36
757 PRODUCT ADMINISTRATION INTERRUPTED 36
758 PRODUCT DISTRIBUTION ISSUE 36
759 VENTRICULAR EXTRASYSTOLES 36
760 WRONG TECHNIQUE IN DRUG USAGE PROCESS 36
761 ANKLE FRACTURE 35
762 ASCITES 35
763 BENIGN PROSTATIC HYPERPLASIA 35
764 C-REACTIVE PROTEIN ABNORMAL 35
765 DEVICE USE ISSUE 35
766 DIALYSIS 35
767 DRUG DISPENSING ERROR 35
768 INCREASED UPPER AIRWAY SECRETION 35
769 LUNG INFECTION 35
770 MYOSITIS 35
771 PRODUCT PRESCRIBING ERROR 35
772 PURPURA 35
773 RASH MACULO-PAPULAR 35
774 RENAL TUBULAR NECROSIS 35
775 SENSATION OF FOREIGN BODY 35
776 SKIN HYPERPIGMENTATION 35
777 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 35
778 SMALL INTESTINAL OBSTRUCTION 35
779 VITAMIN D DEFICIENCY 35
780 CONJUNCTIVITIS ALLERGIC 34
781 DRUG DEPENDENCE 34
782 EXTRASYSTOLES 34
783 HAEMORRHAGIC ANAEMIA 34
784 INFUSION SITE ERYTHEMA 34
785 INITIAL INSOMNIA 34
786 PARALYSIS 34
787 POLYURIA 34
788 POOR VENOUS ACCESS 34
789 VENTRICULAR TACHYCARDIA 34
790 ACUTE RESPIRATORY DISTRESS SYNDROME 33
791 BOWEL MOVEMENT IRREGULARITY 33
792 CLOSTRIDIUM DIFFICILE COLITIS 33
793 CORNEAL ABRASION 33
794 CYTOKINE RELEASE SYNDROME 33
795 HAEMORRHAGIC STROKE 33
796 HEPATITIS 33
797 HIP ARTHROPLASTY 33
798 HYPERCALCAEMIA 33
799 MASS 33
800 ONYCHOCLASIS 33
801 PARANOIA 33
802 PSYCHOTIC DISORDER 33
803 RETINAL TEAR 33
804 SENSORY DISTURBANCE 33
805 SKIN HAEMORRHAGE 33
806 WHITE BLOOD CELL COUNT ABNORMAL 33
807 APPLICATION SITE PAIN 32
808 BLADDER CANCER 32
809 BURSITIS 32
810 CONJUNCTIVAL HAEMORRHAGE 32
811 CROHN^S DISEASE 32
812 DEVICE DIFFICULT TO USE 32
813 ENDOPHTHALMITIS 32
814 EXOSTOSIS 32
815 EYE BURNS 32
816 HAEMOGLOBIN ABNORMAL 32
817 HEPATIC STEATOSIS 32
818 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 32
819 NEUTROPHIL COUNT INCREASED 32
820 ORAL MUCOSAL BLISTERING 32
821 SUPERFICIAL INJURY OF EYE 32
822 TACHYPNOEA 32
823 TENDON RUPTURE 32
824 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 32
825 ANGIOPATHY 31
826 BACK INJURY 31
827 BLOOD THYROID STIMULATING HORMONE INCREASED 31
828 BODY TEMPERATURE INCREASED 31
829 CARDIAC PACEMAKER INSERTION 31
830 DENTAL CARIES 31
831 DYSGRAPHIA 31
832 FLUID OVERLOAD 31
833 HYPHAEMA 31
834 INCORRECT STORAGE OF DRUG 31
835 MYDRIASIS 31
836 NASAL DRYNESS 31
837 PELVIC FRACTURE 31
838 PERIORBITAL OEDEMA 31
839 PETECHIAE 31
840 PNEUMOTHORAX 31
841 PUNCTATE KERATITIS 31
842 SPINAL COMPRESSION FRACTURE 31
843 STEVENS-JOHNSON SYNDROME 31
844 ABNORMAL LOSS OF WEIGHT 30
845 ABORTION SPONTANEOUS 30
846 BLEPHARAL PIGMENTATION 30
847 BLOOD PRESSURE DIASTOLIC DECREASED 30
848 CYST 30
849 DEVICE RELATED INFECTION 30
850 DIABETIC NEUROPATHY 30
851 DRUG PRESCRIBING ERROR 30
852 HYPERKERATOSIS 30
853 INCONTINENCE 30
854 INFUSION SITE SWELLING 30
855 LUNG INFILTRATION 30
856 METAMORPHOPSIA 30
857 METASTASES TO LIVER 30
858 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30
859 OCULAR SURFACE DISEASE 30
860 OPTIC NERVE INJURY 30
861 ORAL CANDIDIASIS 30
862 SCAR 30
863 SEDATION 30
864 ACIDOSIS 29
865 ADRENAL INSUFFICIENCY 29
866 ALTERED STATE OF CONSCIOUSNESS 29
867 BACTERAEMIA 29
868 BLOOD CHOLESTEROL ABNORMAL 29
869 BONE DENSITY DECREASED 29
870 BRAIN FOG 29
871 CORNEAL DEPOSITS 29
872 CREPITATIONS 29
873 DRUG-INDUCED LIVER INJURY 29
874 DYSLIPIDAEMIA 29
875 EMOTIONAL DISORDER 29
876 EYELASH THICKENING 29
877 HYPERTHYROIDISM 29
878 INCORRECT DRUG ADMINISTRATION DURATION 29
879 INCORRECT PRODUCT ADMINISTRATION DURATION 29
880 LYMPHOEDEMA 29
881 LYMPHOPENIA 29
882 MOOD ALTERED 29
883 NEPHROPATHY 29
884 OCULAR VASCULAR DISORDER 29
885 PERSONALITY CHANGE 29
886 PRODUCT RESIDUE PRESENT 29
887 RED CELL DISTRIBUTION WIDTH INCREASED 29
888 SARS-COV-2 TEST POSITIVE 29
889 SCRATCH 29
890 TOOTH EXTRACTION 29
891 TRICUSPID VALVE INCOMPETENCE 29
892 ACUTE MYELOID LEUKAEMIA 28
893 ANGIOPLASTY 28
894 BREAST PAIN 28
895 CARDIAC VALVE DISEASE 28
896 COLD SWEAT 28
897 CONCUSSION 28
898 DECUBITUS ULCER 28
899 DIVERTICULUM INTESTINAL 28
900 DRUG TOXICITY 28
901 DUODENAL ULCER 28
902 FACE OEDEMA 28
903 FOREIGN BODY IN EYE 28
904 IMMUNODEFICIENCY 28
905 INJECTION SITE RASH 28
906 LYMPHOMA 28
907 MYOCARDIAL ISCHAEMIA 28
908 NEEDLE ISSUE 28
909 OSTEONECROSIS 28
910 PEMPHIGOID 28
911 PERIORBITAL PAIN 28
912 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 28
913 PROCEDURAL PAIN 28
914 SPINAL OPERATION 28
915 WRONG DRUG ADMINISTERED 28
916 ARTERIOSCLEROSIS 27
917 ARTERIOSCLEROSIS CORONARY ARTERY 27
918 CYTOPENIA 27
919 DEAFNESS UNILATERAL 27
920 DEVICE OCCLUSION 27
921 EJECTION FRACTION DECREASED 27
922 FAECALOMA 27
923 GLUCOSE TOLERANCE IMPAIRED 27
924 HEMIPLEGIA 27
925 HEPATIC FAILURE 27
926 HEPATOMEGALY 27
927 HYPERCHOLESTEROLAEMIA 27
928 INTENTIONAL DRUG MISUSE 27
929 LACERATION 27
930 MALNUTRITION 27
931 MYOPIA 27
932 PERIPHERAL VENOUS DISEASE 27
933 PRODUCT LABEL ISSUE 27
934 PROSTATIC DISORDER 27
935 QUALITY OF LIFE DECREASED 27
936 RETINAL VEIN OCCLUSION 27
937 SINUS TACHYCARDIA 27
938 TARDIVE DYSKINESIA 27
939 TENDERNESS 27
940 VITREOUS DETACHMENT 27
941 AORTIC ANEURYSM 26
942 BLOOD CALCIUM INCREASED 26
943 BLOOD TEST ABNORMAL 26
944 COMPRESSION FRACTURE 26
945 COORDINATION ABNORMAL 26
946 DEAFNESS NEUROSENSORY 26
947 DECREASED ACTIVITY 26
948 DEVICE BREAKAGE 26
949 DISABILITY 26
950 GASTROINTESTINAL PAIN 26
951 HORDEOLUM 26
952 INSTILLATION SITE ERYTHEMA 26
953 LABYRINTHITIS 26
954 MANIA 26
955 MOOD SWINGS 26
956 MULTIPLE ALLERGIES 26
957 MUSCLE STRAIN 26
958 MYASTHENIA GRAVIS 26
959 NASAL DISCHARGE DISCOLOURATION 26
960 NIKOLSKY^S SIGN POSITIVE 26
961 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 26
962 PERICARDITIS 26
963 RHINITIS ALLERGIC 26
964 SKIN ABRASION 26
965 SQUAMOUS CELL CARCINOMA 26
966 VAGINAL HAEMORRHAGE 26
967 VASCULITIS 26
968 INCORRECT DOSE ADMINISTERED BY DEVICE 25
969 INJECTION SITE MASS 25
970 METASTASES TO BONE 25
971 MOUTH HAEMORRHAGE 25
972 MUCOSAL INFLAMMATION 25
973 PRODUCT DESIGN ISSUE 25
974 PRODUCT ODOUR ABNORMAL 25
975 SUPRAVENTRICULAR TACHYCARDIA 25
976 WALKING AID USER 25
977 ABDOMINAL HERNIA 24
978 ABSCESS 24
979 ANGINA UNSTABLE 24
980 APPLICATION SITE ERYTHEMA 24
981 CYANOSIS 24
982 DENTAL RESTORATION FAILURE 24
983 DIABETIC RETINOPATHY 24
984 DRUG LEVEL INCREASED 24
985 ELECTROCARDIOGRAM ABNORMAL 24
986 EYE MOVEMENT DISORDER 24
987 HEPATOCELLULAR INJURY 24
988 IMMUNE SYSTEM DISORDER 24
989 IMPAIRED GASTRIC EMPTYING 24
990 INABILITY TO AFFORD MEDICATION 24
991 LIVER INJURY 24
992 MUSCLE DISORDER 24
993 OPHTHALMOPLEGIA 24
994 PAIN OF SKIN 24
995 PRESCRIBED OVERDOSE 24
996 PRODUCT LEAKAGE 24
997 PRODUCT PHYSICAL CONSISTENCY ISSUE 24
998 PROSTATOMEGALY 24
999 RALES 24